Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8599-8611

  Pizzato, Massimo ^a,d   Marlow, Susan A ^b   Blair, Edward D ^c   Takeuchi, Yasuhiro ^a,d  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOFLUORESCENCE; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

EID: 0032823293     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8599-8611.1999     Document Type: Article

References (45)

1. Allison, A. C., and R. C. Valentine. 1959. Viras particle adsorption. 1. Theory of adsorption and experiments on the attachment of particles to non-biological surfaces. Biochim. Biophys. Acta 34:10-23.
2. Allison, A. C., and R. C. Valentine. 1959. Virus particle adsorption. II. Adsorption of vaccinia and fowl plaque viruses to cells in suspension. Biochim. Biophys. Acta 40:393-399.
3. Allison, A. C., and R. C. Valentine. 1959. Virus particle adsorption. III. Adsorption of viruses by cell monolayers and effect of some variables on adsorption. Biochim. Biophys. Acta. 40:400-410.
4. Bartlett, J. S., and R. J. Samulski. 1998. Fluorescent viral vectors: a new technique for the pharmacological analysis of gene therapy. Nat. Med. 4:635-637.
5. Battini, J. L., P. Rodrigues, R. Muller, O. Danos, and J. M. Heard. 1996. Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J. Virol. 70:4387-4393.
6. Chillakuru, R. A., D. D. Ryu, and T. Yilma. 1991. Propagation of recombinant vaccinia virus in HeLa cells: adsorption kinetics and replication in batch cultures. Biotechnol. Prog. 7:85-92.
7. Chuck, A. S., M. F. Clarke, and B. O. Palsson. 1996. Retroviral infection is limited by Brownian motion. Hum. Gene Ther. 7:1527-1534.
8. Cosset, F. L., F. J. Morling, Y. Takeuchi, R. A. Weiss, M. K. Collins, and S. J. Russell. 1995. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:6314-6322.
9. Cosset, F. L., and S. J. Russell. 1996. Targeting retrovirus entry. Gene Ther. 3:946-956.
10. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol 69:7430-7436.
11. Daniel, R., R. A. Katz, and A. M. Skalka. 1999. A role for DNA-PK in retroviral DNA integration. Science 284:644-647.
12. DeLarco, J., and G. J. Todaro. 1976. Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. Cell 8:365-371.
13. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. J. Britt. 1990. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:6176-6183.
14. Fortin, J. F., R. Cantin, G. Lamontagne, and M. Tremblay. 1997. Hostderived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:3588-3596.
15. Frank, H., H. Schwarz, T. Grat, and W. Schafer. 1978. Properties of mouse leukemia viruses. XV. Electron microscopic studies on the organization of Friend leukemia virus and other mammalian C-type viruses. Z Naturforsch Ser. C 33:124-138.
16. Gaken, J. A., M. Tavassoli, S. U. Gan, S. Vallian, I. Giddings, D. C. Darling, J. Galea-Lauri, M. G. Thomas, H. Abedi, V. Schreiber, J. Menissier-de Murcia, M. K. Collina, S. Shall, and F. Farzaneh. 1996. Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity. J. Virol. 70:3992-4000.
17. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94:9825-9830.
18. Ganguly, K., V. S. Kalyanaraman, and M. G. Sarngadharan. 1983. Analysis of the interaction between Rauscher murine leukemia virus and murine cell membrane receptor by in vitro binding assay. Cancer Lett. 18:79-86.
19. Kadan, M. J., S. Sturm, W. F. Anderson, and M. A. Eglitis. 1992. Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis, J. Virol. 66:2281-2287.
20. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
21. Kozak, S. L., D. C. Siess, M. P. Kavanaugh, A. D. Miller, and D. Kabat. 1995. The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J. Virol. 69:3433-3440.
22. Leopold, P. L., B. Ferris, I. Grinberg, S. Worgall, N. R. Hackett, and R. G. Crystal. 1998. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9:367-378.
23. Marechal, V., F. Clavel, J. M. Heard, and O. Schwartz. 1998. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72:2208-2212.
24. Martin, F., J. Kupsch, Y. Takeuchi, S. Russell, F. L. Cosset, and M. Collins. 1998. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope. Hum. Gene Ther. 9:737-746.
25. McKeating, J. A., A. McKnight, and J. P. Moore. 1991. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J. Virol. 65:852-860.
26. McKnight, A., R. A. Weiss, C. Shotton, Y. Takeuchi, H. Hoshino, and P. R. Clapham. 1995. Change in tropism upon immune escape by human immunodeficiency virus. J. Virol. 69:3167-3170.
27. Mittereder, N., K. L. March, and B. C. Trapnell. 1996. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70:7498-7509.
28. Mondor, I., S. Ugolini, and Q. J. Sattentau. 1998. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72:3623-3634.
29. Nermut, M. V., H. Frank, and W. Schafer. 1972. Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology 49:345-358.
30. Notter, M. F., J. F. Leary, and P. C. Balduzzi. 1982. Adsorption of Rous sarcoma virus to genetically susceptible and resistant chicken cells studied by laser flow cytometry. J. Virol. 41:958-964.
31. Paquette, J. S., J. F. Fortin, L. Blanchard, and M. J. Tremblay. 1998. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J. Virol. 72:9329-9336.
32. Piraino, F. 1967. The mechanism of genetic resistance of chick embryo cells to infection by Rous sarcoma virus-BRYAN strain (BS-RSV). Virology 32:700.
33. Pudney, J., and M. J. Song. 1994. Electron microscopic analysis of HIV-host cell interactions. Tissue Cell 24:539-550.
34. Schlegel, R., M. C. Willingham, and I. H. Pastan. 1982. Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells. J. Virol. 43:871-875.
35. Smith, R. E. 1974. High specific infectivity avian RNA tumor viruses. Virology 60:543-547.
36. Tailor, C. S., Y. Takeuchi, B. O'Hara, S. V. Johann, R. A. Weiss, and M. K. Collins. 1993. Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. J. Virol. 67:6737-6741.
37. Takeuchi, Y., M. Akutsu, K. Murayama, N. Shimizu, and H. Hoshino. 1991. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J. Virol. 65:1710-1718.
38. Tavoloni, N. 1997. A simple procedure to determine the biological titer of recombinant retroviral vectors. Gene Ther. 4:150-155.
39. Valenzuela, A., J. Blanco, B. Knut, R. Franco, and A. G. Hovanessian. 1997. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells. J. Virol. 71:8289-8298.
40. Vanderplasschen, A., and G. L. Smith. 1997. A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J. Virol. 71:4032-4041.
41. Wang, H., R. Paul, R. E. Burgeson, D. R. Keene, and D. Rabat. 1991. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J. Virol. 65:6468-6477.
42. Weiss, R. A. 1993. Cellular receptor and viral glycoproteins involved in retrovirus entry, p. 1-108. In J. A. Levy (ed.), The Retroviridae, vol. 2. Plenum Press, New York, N.Y.
43. Yu, H., C. Empig, J. Xia, and W. F. Anderson. 1998. Quantitation of MoMuLV envelope protein on the cell surface. Virology 243:415-422.
44. Yu, H., N. Soong, and W. F. Anderson. 1995. Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J. Virol. 69:6557-6562.
45. Zheng, Y. Z., R. Webb, P. F. Greenfield, and S. Reid. 1996. Improved method for counting virus and virus like particles. J. Virol. Methods 62:153-159.